Long term melatonin use
Pro Research Analysisby 
Searched over 200M research papers
Long-Term Melatonin Use: Safety and Efficacy Insights
Introduction to Long-Term Melatonin Use
Melatonin, a hormone that regulates sleep-wake cycles, is widely used as a sleep aid. Its long-term use, however, raises questions about safety and efficacy, especially given its availability as an over-the-counter supplement in many countries. This article synthesizes findings from various studies to provide a comprehensive overview of the long-term use of melatonin.
Safety of Long-Term Melatonin Use
General Safety Profile
Several studies have investigated the safety of long-term melatonin use, generally finding it to be well-tolerated with few serious adverse events. A systematic review of 37 randomized controlled trials (RCTs) reported that the most common adverse events were mild, including daytime sleepiness, headache, dizziness, and hypothermia, with very few serious adverse events noted . Another review emphasized the scarcity of data from long-term, double-blind, randomized placebo-controlled trials, suggesting a need for more rigorous safety evaluations .
Specific Populations
Children and Adolescents
Long-term melatonin use in children, particularly those with neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), has been studied with promising results. A study on children with ADHD and chronic sleep onset insomnia (CSOI) found no serious adverse events over a mean follow-up period of 3.7 years, with 88% of parents reporting continued effectiveness in managing sleep onset problems . Similarly, a study on children with ASD using prolonged-release melatonin (PedPRM) for up to 104 weeks reported no detrimental effects on growth, body mass index (BMI), or pubertal development, and no significant withdrawal or safety issues .
Adults with Chronic Conditions
In adults, particularly those with chronic conditions like type 2 diabetes, melatonin use has shown mixed results. A study on patients with type 2 diabetes found that while melatonin decreased insulin sensitivity by 12%, it also increased the second-phase insulin response, suggesting a complex interaction with glucose metabolism . This indicates that while melatonin may be safe for general use, caution is warranted in specific populations.
Efficacy of Long-Term Melatonin Use
Sleep Disorders
Melatonin has been shown to be effective in managing various sleep disorders over the long term. In children with treatment-resistant circadian rhythm sleep disorders (CRSD), long-term melatonin therapy was associated with improved sleep, health, behavior, and learning, with no evidence of adverse reactions or tolerance development . In adults aged 55 and older with primary insomnia, prolonged-release melatonin significantly improved sleep quality, latency, morning alertness, and health-related quality of life over a 6-month period .
Cancer-Related Fatigue
Melatonin has also been studied for its effects on cancer-related fatigue. A trial involving breast cancer patients found that long-term melatonin use significantly reduced fatigue levels compared to placebo, suggesting potential benefits beyond sleep regulation .
Conclusion
Overall, long-term melatonin use appears to be safe and effective for managing sleep disorders in both children and adults, with few serious adverse events reported. However, the scarcity of long-term, high-quality RCTs highlights the need for further research, particularly in specific populations such as those with chronic health conditions. As always, individuals should consult healthcare providers before starting any long-term melatonin regimen.
Sources and full results
Most relevant research papers on this topic